Arrowhead Presents Data on Pulmonary Pipeline at ERS 2023 - Arrowhead Pharma (NASDAQ:ARWR)
- Arrowhead Expands the Reach of RNAi Therapies to Address Diseases in the Lung - Late-Breaking Clinical Data for ARO-RAGE for Treatment of Asthma Demonstrate Deep and Durable Gene Silencing - Promising Preclinical
Source: benzinga.com